Concepedia

Anne‐Catherine Abel

AA

Statistics

Publications

4

Citations

82

H-Index

4

Active since

2021

Affiliations

Paul Scherrer Institute(Current)

University of Basel

Anne‐Catherine Abel is an author at Paul Scherrer Institute specializing in drug discovery, medicinal chemistry, and cancer pharmacology.

ORCID

Publications per year

2021–2024

4

Publications

4

Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas

Marilia Barreca, Virginia Spanò, Roberta Rocca et al. · European Journal of Medicinal Chemistry · 2022 · 45 citations · Full text

, , +15

1,3‐Benzodioxole‐Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin‐Bound Structure

Cassandra Yong, Shane M. Devine, Anne‐Catherine Abel et al. · ChemMedChem · 2021 · 14 citations · Full text

, , +13

Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders

Paola Marzullo, Zlata Boiarska, Helena Pérez‐Peña et al. · Chemistry - A European Journal · 2021 · 13 citations · Full text

, , +12

Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin’s T5-loop

Anne‐Catherine Abel, Tobias Mühlethaler, Cedric Dessin et al. · Journal of Biological Chemistry · 2024 · 10 citations · Full text

, , +17

1–4 of 4